Evidence map›Paper›PMID 24669349›Full record

ArticleAnnals of medical and health sciences research2014

Hydroxycut-induced Liver Toxicity.

Dh Kaswala, S Shah, N Patel, S Raisoni, S Swaminathan

Abstract readCase Reports
In one paragraph

Article in Annals of medical and health sciences research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Toxicity Potential of Nutraceuticals.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Review
  4. Hepatotoxicity due to herbal dietary supplements: Past, present and the future.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2022
    Review
  5. Body Building and Aminotransferase Elevations: A Review.Journal of clinical and translational hepatology · 2020
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Dangerous dietary supplements:World journal of gastroenterology · 2016
    Article
  11. Review
  12. Review
  13. Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review.Journal of clinical and translational hepatology · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dh KaswalaDepartment of Medicine, University Hospital, Rutgers-New Jersey Medical School (Formerly UMDNJ-NJMS), Newark, NJ, USA.
S ShahDepartment of Medicine, University Hospital, Rutgers-New Jersey Medical School (Formerly UMDNJ-NJMS), Newark, NJ, USA.
N PatelDepartment of Medicine, University Hospital, Rutgers-New Jersey Medical School (Formerly UMDNJ-NJMS), Newark, NJ, USA.
S RaisoniDepartment of Medicine, University Hospital, Rutgers-New Jersey Medical School (Formerly UMDNJ-NJMS), Newark, NJ, USA.
S SwaminathanDepartment of Medicine, University Hospital, Rutgers-New Jersey Medical School (Formerly UMDNJ-NJMS), Newark, NJ, USA.
University Hospital, Newark · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the recent era, use of various nutritional supplements is highly encouraged amongst the people of United States. Weight loss supplements are major part of the nutritional supplements and their usage is unregulated in the US. Obesity is a major health concern in the US and Americans spend around $30 billion a year for weight loss supplements. At times, these supplements can be responsible for documented or undocumented adverse drug effects. The health consequences related to these supplements are often overlooked by the general public, even though FDA issues advisories regarding them. One common supplement used for weight loss was Hydroxycut (Iovate Health Sciences Research, Oakville, Ontario, Canada). Hydroxycut was recalled from the market after a FDA warning in May 2009 because of 23 reports of serious health problems ranging from jaundice and elevated liver enzymes to liver damage. 1 This case report adds evidence for Hydroxycut - induced hepatotoxicity. A 27 year old man with right upper quadrant pain and jaundice was found to have elevated liver enzymes and was taking Hydroxycut along with other supplements. Liver biopsy showed drug induced hepatotoxicity. Discontinuation of Hydroxycut dramatically improved liver functions and related symptoms.

Indexed as

HydroxycutLiver toxicityNutritional supplements

Identifiers

PMID24669349
PMCPMC3952288
OpenAlexW2151187984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.